Q1 2018 Earnings Estimate for UnitedHealth Group Inc Issued By Oppenheimer (UNH)
UnitedHealth Group Inc (NYSE:UNH) – Research analysts at Oppenheimer increased their Q1 2018 earnings per share estimates for shares of UnitedHealth Group in a report released on Tuesday. Oppenheimer analyst M. Wiederhorn now anticipates that the healthcare conglomerate will post earnings per share of $2.92 for the quarter, up from their prior forecast of $2.50. Oppenheimer currently has a “Outperform” rating and a $240.00 target price on the stock. Oppenheimer also issued estimates for UnitedHealth Group’s Q3 2018 earnings at $3.31 EPS, Q4 2018 earnings at $3.25 EPS, FY2018 earnings at $12.45 EPS, Q1 2019 earnings at $3.17 EPS, Q2 2019 earnings at $3.21 EPS, Q3 2019 earnings at $3.54 EPS and Q4 2019 earnings at $3.46 EPS.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same quarter last year, the business posted $2.11 EPS. The business’s revenue was up 9.5% on a year-over-year basis.
UnitedHealth Group (UNH) traded down $0.82 during midday trading on Friday, reaching $242.34. The company’s stock had a trading volume of 1,410,402 shares, compared to its average volume of 3,634,767. UnitedHealth Group has a 1-year low of $156.49 and a 1-year high of $243.90. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58. The stock has a market cap of $234,490.00, a PE ratio of 22.63, a P/E/G ratio of 1.45 and a beta of 0.66.
A number of hedge funds have recently bought and sold shares of UNH. Capital International Investors increased its position in UnitedHealth Group by 399.3% during the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after buying an additional 3,304,902 shares in the last quarter. Jennison Associates LLC increased its holdings in shares of UnitedHealth Group by 146.0% in the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after purchasing an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC increased its holdings in shares of UnitedHealth Group by 1,820.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after purchasing an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares in the last quarter. Finally, Parametric Portfolio Associates LLC increased its holdings in shares of UnitedHealth Group by 77.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after purchasing an additional 1,562,661 shares in the last quarter. 86.09% of the stock is owned by institutional investors.
In related news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the transaction, the director now owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $222.20, for a total value of $1,111,000.00. Following the transaction, the director now directly owns 36,989 shares of the company’s stock, valued at approximately $8,218,955.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,655 shares of company stock valued at $7,469,083. 0.89% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: “Q1 2018 Earnings Estimate for UnitedHealth Group Inc Issued By Oppenheimer (UNH)” was reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.watchlistnews.com/q1-2018-earnings-estimate-for-unitedhealth-group-inc-issued-by-oppenheimer-unh/1813840.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.